"Nuclear Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus.
Descriptor ID |
D009687
|
MeSH Number(s) |
D12.776.660
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nuclear Proteins".
Below are MeSH descriptors whose meaning is more specific than "Nuclear Proteins".
This graph shows the total number of publications written about "Nuclear Proteins" by people in this website by year, and whether "Nuclear Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 2 | 4 |
1995 | 2 | 1 | 3 |
1996 | 15 | 3 | 18 |
1997 | 12 | 3 | 15 |
1998 | 7 | 6 | 13 |
1999 | 9 | 10 | 19 |
2000 | 21 | 7 | 28 |
2001 | 12 | 9 | 21 |
2002 | 16 | 8 | 24 |
2003 | 19 | 8 | 27 |
2004 | 13 | 11 | 24 |
2005 | 14 | 10 | 24 |
2006 | 13 | 5 | 18 |
2007 | 11 | 3 | 14 |
2008 | 5 | 7 | 12 |
2009 | 20 | 16 | 36 |
2010 | 16 | 8 | 24 |
2011 | 13 | 14 | 27 |
2012 | 23 | 8 | 31 |
2013 | 19 | 9 | 28 |
2014 | 16 | 11 | 27 |
2015 | 16 | 7 | 23 |
2016 | 12 | 7 | 19 |
2017 | 13 | 9 | 22 |
2018 | 14 | 10 | 24 |
2019 | 10 | 3 | 13 |
2020 | 4 | 4 | 8 |
2021 | 4 | 6 | 10 |
2022 | 1 | 7 | 8 |
2023 | 1 | 5 | 6 |
2024 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nuclear Proteins" by people in Profiles.
-
A unifying model for membrane protein biogenesis. Nat Struct Mol Biol. 2024 Jul; 31(7):1009-1017.
-
CUX1 regulates human hematopoietic stem cell chromatin accessibility via the BAF complex. Cell Rep. 2024 May 28; 43(5):114227.
-
SETBP1 sets the stage. Blood. 2024 Apr 04; 143(14):1323-1324.
-
Structure-Guided Design and Synthesis of Pyridinone-Based Selective Bromodomain and Extra-Terminal Domain (BET)-First Bromodomain (BD1) Inhibitors. J Med Chem. 2024 Feb 22; 67(4):2712-2731.
-
Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow. Mod Pathol. 2024 Jan; 37(1):100352.
-
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC. Cancer Discov. 2023 07 07; 13(7):1556-1571.
-
Concurrent high-grade glioma with cavernous malformations and pathogenic variants in PDCD10 and SMARCA4. Childs Nerv Syst. 2023 11; 39(11):3311-3315.
-
The nuclear envelope and metastasis. Oncotarget. 2023 04 14; 14:317-320.
-
Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group. Leuk Lymphoma. 2023 05; 64(5):972-980.
-
Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group. JCO Precis Oncol. 2023 01; 7:e2200400.